StockWatch
·
Commodity Chemicals
Board Meeting11 Nov 2026, 05:50 pm

Fischer Medical Ventures Board Meeting on Nov 14, 2026

AI Summary

Fischer Medical Ventures Ltd has announced that its Board of Directors will convene on November 14, 2026, via video conferencing. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Additionally, the board will address any other matters as specified in the agenda. The company also reiterated that the trading window for its equity shares remains closed for designated persons and related parties until 48 hours after the declaration of these financial results.

Key Highlights

  • Board meeting scheduled for November 14, 2026.
  • To consider unaudited standalone and consolidated financial results.
  • Results pertain to the quarter and half-year ended September 30, 2026.
  • Trading window remains closed until 48 hours post-results declaration.